Related Experiment Videos
Clinical advances in mastocytosis
A Genovese1, G Spadaro, M Triggiani
1School of Medicine, University of Naples Federico II, Italy.
International Journal of Clinical & Laboratory Research
|January 1, 1995
Summary
Mastocytosis involves abnormal mast cell proliferation, likely linked to the c-kit receptor pathway. Diagnosis and evaluation of systemic mastocytosis can utilize measurements of mast cell mediators.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Mastocytosis is characterized by excessive mast cell proliferation.
- The exact triggers for mast cell proliferation in mastocytosis remain largely unknown.
- The c-kit receptor and stem cell factor pathway are implicated in mast cell growth and differentiation.
Purpose of the Study:
- To describe the diverse clinical spectrum of mastocytosis.
- To highlight the role of mast cell mediators in disease symptoms.
- To discuss diagnostic approaches for systemic mastocytosis.
Main Methods:
- Clinical observation and classification of mastocytosis.
- Analysis of mast cell mediator release.
- Laboratory evaluation of body fluids for mediators like histamine and tryptase.
Main Results:
- Mastocytosis presents as a spectrum, varying by mast cell proliferation, organ involvement, age, and associated hematologic conditions.
- Symptoms are typically caused by the release of mast cell mediators (e.g., histamine, prostaglandin D2).
- Measurement of mediators aids in diagnosing and evaluating systemic mastocytosis.
Conclusions:
- Mastocytosis encompasses a range of conditions from skin-limited to systemic forms.
- Understanding the pathogenesis is crucial for effective treatment, which is often symptomatic.
- Further research into mastocytosis pathogenesis is needed.